Anuzoprokt (Suppositories) Instructions for Use
Marketing Authorization Holder
Tula Pharmaceutical Factory, LLC (Russia)
ATC Code
C05AX02 (Bismuth preparations in combination with other drugs)
Active Substances
Iodine (Ph.Eur.)
Zinc oxide (Ph.Eur.)
Bismuth subnitrate (USAN)
Dosage Form
| Anuzoprokt | Rectal suppositories: from 1 to 100 pcs. |
Dosage Form, Packaging, and Composition
Rectal suppositories of a grayish-green or bluish-green color, torpedo-shaped; the appearance of a white coating on the surface is allowed.
| 1 supp. | |
| Bismuth subnitrate | 0.075 g |
| Zinc oxide | 0.2 g |
| Iodine | 0.005 g |
Excipients: tannin – 0.05 g, resorcinol – 0.005 g, methylthioninium chloride – 0.003 g, hard fat type A – 2.001 g, emulsifier T-2 – 0.041 g.
From 1 to 10 pcs. – contour cell packaging (from 1 to 10 pcs.) – cardboard packs.
Clinical-Pharmacological Group
A drug with anti-inflammatory, astringent, drying, and local anesthetic action for topical use in proctology
Pharmacotherapeutic Group
Angioprotectors; agents for the treatment of hemorrhoids and anal fissures for topical use; other agents for the treatment of hemorrhoids and anal fissures for topical use
Pharmacological Action
Antihemorrhoidal agent. It has antiseptic and astringent action.
Indications
- Hemorrhoids for the relief of symptoms including inflammation, swelling, and discomfort.
- Anal fissures to promote healing and provide symptomatic relief from pain and irritation.
Use specifically for conditions where an astringent, antiseptic, and local anti-inflammatory effect is required in the anorectal area.
ICD codes
| ICD-10 code | Indication |
| K60 | Fissure and fistula of anus and rectum |
| K64 | Hemorrhoids and perianal venous thrombosis |
| ICD-11 code | Indication |
| DB50.Z | Fissure or fistula of anal region, unspecified |
| DB6Z | Hemorrhoids or perianal venous diseases, unspecified |
| DE2Z | Diseases of the digestive system, unspecified |
Dosage Regimen
| The method of application and dosage regimen for a specific drug depend on its form of release and other factors. The optimal dosage regimen is determined by the doctor. It is necessary to strictly adhere to the compliance of the dosage form of a specific drug with the indications for use and dosage regimen. |
Administer rectally. Use one suppository inserted into the rectum, typically one to two times per day, or as directed by a physician.
The frequency and duration of therapy depend on the severity of symptoms. Cleanse the anal area before insertion. If symptoms persist beyond 7-10 days, discontinue use and consult a doctor.
Adverse Reactions
Localized allergic reactions are possible, manifesting as skin rash, itching, redness, or irritation at the application site.
Discontinue use immediately if any signs of hypersensitivity appear. The incidence of these reactions is generally low but monitor for any unusual local symptoms during treatment.
Contraindications
- Hypersensitivity to any of the active substances (iodine, zinc oxide, bismuth subnitrate) or to any of the excipients.
- Known iodine intolerance, due to the potential for severe allergic reactions.
Do not use in patients with a history of allergic contact dermatitis to any component of the suppository formulation.
Drug Interactions
Formal interaction studies have not been conducted. Due to the local action and low systemic absorption, clinically significant drug interactions are not anticipated.
Concurrent use with other topical anorectal preparations is not recommended to avoid potential local irritation or incompatibility. Inform your physician about all medications you are using.
Overdose
Overdose with rectal suppositories is unlikely due to the local route of administration. Excessive use could potentially lead to intensified local adverse effects such as severe irritation.
In case of suspected overdose, discontinue treatment and manage symptoms supportively. There is no specific antidote. Seek medical attention if severe local reactions occur.
Use in Pregnancy and Lactation
Use during pregnancy and breastfeeding is only possible if the intended benefit to the mother outweighs the potential risk to the fetus or child.
If it is necessary to use the product during pregnancy or while breastfeeding, a doctor should be consulted beforehand.
Special Precautions
If after 7-10 days of treatment there is no improvement in the condition, or the symptoms worsen, or new symptoms appear, it is necessary to consult a doctor.
Storage Conditions
Store at 2°C (36°F) to 15°C (59°F). Keep in original packaging, protected from light. Keep out of reach of children.
Dispensing Status
Over-the-Counter
Important Safety Information
This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.
Medical Disclaimer
Noopept, pills 10mg, 50pcs
No-spa pills 40mg, 64pcs
Daivobet, ointment, 30g
Cerebrolysin, solution for injection 2ml ampoules 10pcs
Arbidol, capsules 100mg, 40pcs
Picamilon pills 50mg, 60pcs
Cortexin, 10mg, 5ml, 10pcs
Phenibut-Vertex pills 250mg, 20pcs
Belosalic, lotion solution for external use spray 100ml
Fenotropil pills 100mg, 60pcs
Cavinton Comfort, dispersible pills 10mg 90pcs
Belosalic, ointment, 30g
Ingavirin capsules 90mg, 10pcs
OKI, sachets 80mg 2g, 12pcs
Mildronate capsules 500mg, 90pcs
Kagocel pills 12mg, 30pcs
Nootropil pills 800mg, 30pcs
Actovegin pills 200mg, 50pcs 